Compare DHI & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DHI | CNC |
|---|---|---|
| Founded | 1978 | 1984 |
| Country | United States | United States |
| Employees | 14341 | N/A |
| Industry | Homebuilding | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.6B | 33.5B |
| IPO Year | 1995 | 2001 |
| Metric | DHI | CNC |
|---|---|---|
| Price | $137.89 | $66.40 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 16 |
| Target Price | ★ $166.08 | $46.75 |
| AVG Volume (30 Days) | 1.6M | ★ 2.7M |
| Earning Date | 04-21-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.19% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 7.45 | 5.30 |
| Revenue | $34,250,400,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $0.05 | $8.31 |
| Revenue Next Year | $5.85 | $1.05 |
| P/E Ratio | $18.65 | ★ $12.09 |
| Revenue Growth | N/A | ★ 19.44 |
| 52 Week Low | $131.75 | $31.63 |
| 52 Week High | $177.58 | $69.36 |
| Indicator | DHI | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 35.61 | 51.08 |
| Support Level | $132.80 | $63.36 |
| Resistance Level | $153.01 | $68.39 |
| Average True Range (ATR) | 3.01 | 1.96 |
| MACD | -1.06 | -0.06 |
| Stochastic Oscillator | 7.98 | 55.84 |
D.R. Horton is the largest homebuilder in the United States with operations in 126 markets across 36 states. D.R. Horton mainly builds single-family homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. The firm has majority ownership of Forestar Group, a publicly traded residential lot development company. D.R. Horton's headquarters are in Arlington, Texas.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.